← Open Payments lookup

PERSIA COLEMAN: Open Payments

NPI 1861825341 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$741 in 34 payments from 9 companies in 2025. Trend: 2023 $431 · 2024 $64 · 2025 $741

Food & beverage: $741
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$193
ABBVIE INC.9$175
Alkermes, Inc.4$103
Janssen Pharmaceuticals, Inc4$91
Otsuka America Pharmaceutical, Inc.3$65
Axsome Therapeutics, Inc.2$45
Neurocrine BioSciences, Inc.1$31
Supernus Pharmaceuticals, Inc.1$23
Takeda Pharmaceuticals U.S.A., Inc.1$14

Products named: CAPLYTA, VRAYLAR, ARISTADA, REXULTI, SPRAVATO, Auvelity, INVEGA SUSTENNA, INGREZZA.

Industry payments across NV — which companies pay providers there.